Clinical Trials Directory

Trials / Completed

CompletedNCT06614881

Dexmedetomidine Dosage for Postoperative Delirium and Cognitive Function in Elderly TKA Patients

Optimal Effective Dose of Dexmedetomidine on Postoperative Delirium and Cognitive Function of Elderly Patients Planned For TKA Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
132 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
35 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the efficacy of dexmedetomidine in reducing the incidence of postoperative delirium and cognitive dysfunction in elderly patients undergoing total knee arthroplasty (TKA). The study will compare the outcomes of patients receiving dexmedetomidine to those receiving a standard anesthetic or sedative, focusing on factors such as patient characteristics, surgical duration, and postoperative care. The research will explore the potential neuroprotective effects of dexmedetomidine and its ability to mitigate the risks associated with anesthesia and surgery in vulnerable elderly populations.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidine Injection [Precedex]Dexmedetomidine (Precedex, 100 µg/ml) was provided as an intravenous (IV) loading dose of 1 µg/kg over 10-min
DRUGDexmedetomidine in 0.9 % NaCl 1,000 Mcg/250 mL (4 Mcg/mL) INTRAVEN INFUSION BOTTLE (ML)Dexmedetomidine infusions were prepared to provide 0.5 µg/kg/h
DRUGDexmedetomidine in 0.9 % NaCl 1,000 Mcg/250 mL (4 Mcg/mL) INTRAVEN INFUSION BOTTLE (ML)Dexmedetomidine infusions were prepared to provide 0.7 µg/kg/h
DRUGDexmedetomidine in 0.9 % NaCl 1,000 Mcg/250 mL (4 Mcg/mL) INTRAVEN INFUSION BOTTLE (ML)Dexmedetomidine infusions were prepared to provide 1.1 µg/kg/h
DRUGNormal salineloading dose of saline was injected 10-min before induction of anesthesia.

Timeline

Start date
2024-07-01
Primary completion
2024-10-15
Completion
2024-11-01
First posted
2024-09-26
Last updated
2024-11-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06614881. Inclusion in this directory is not an endorsement.